Healio

XEN1101 significantly reduced monthly seizures for adults with focal-onset epilepsy

Please provide your email address to receive an email when new articles are posted on . XEN1101 is a novel small-molecule selective Kv7.2/Kv7.3 potassium channel opener. A 25 mg dose of XEN1101 ...
Nasdaq

CORE-VNS Study Further Validates Effectiveness of LivaNova’s VNS Therapy on Severe Focal Seizures in Both Children and Adults with Drug-Resistant Epilepsy

Long-term, real-world evidence demonstrates early and lasting outcomes of adjunctive VNS Therapy on severe focal seizures The CORE-VNS 36-month data analysis reaffirms the effectiveness of VNS Therapy ...

Cenobamate’s Real-World Impact: A New Hope for Focal Epilepsy?

Detailed price information for Iqvia Holdings Inc (IQV-N) from The Globe and Mail including charting and trades.
Healio

FDA approves Xcopri for oral suspension, nasogastric tube administration

Please provide your email address to receive an email when new articles are posted on . The FDA approved two new delivery methods of Xcopri for adults with partial-onset seizures, with the drug able ...
Morningstar

Praxis Precision Medicines Announces Positive, Best-in-Disease Topline Results in Patients with Focal Onset Seizures from the RADIANT Study of Vormatrigine

BOSTON, Aug. 04, 2025 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for ...
Hosted on MSN

What Causes Seizures in Adults for the First Time?

If you have a first seizure as an adult, it could be an indication of epilepsy, or it may be an isolated episode. Causes in adults include a stroke, head trauma, alcohol withdrawal, brain tumor, or ...